Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-04

Clinical Trial Update: Intracervical Vasopressin [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study evaluating intracervical vasopressin for the condition of retained products of conception, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intracervical vasopressin (vasopressin)

Snippet

Sponsor: Prisma Health-Upstate | Conditions: Retained Products of Conception | Phase 4 | Status: RECRUITING